MEDIGEN VACCINE BIOLOGICS CORPORATE revenue breakdown overview

MEDIGEN VACCINE BIOLOGICS CORPORATE revenue for the last year amounted to 606.00 M TWD, the most of which — 605.43 M TWD — came from its highest performing source at the moment, Vaccine, Biopharmaceutical and Medical Equipment Retail and Wholesale, the year earlier bringing 389.26 M TWD. The greatest contribution to the revenue figure was made by Taiwan — last year it brought MEDIGEN VACCINE BIOLOGICS CORPORATE 605.64 M TWD, and the year before that — 389.62 M TWD.